Monday 7th of February 2022 01:02:53 PM

Amgen Non-GAAP EPS of $4.36 beats by $0.35, revenue of $6.85B misses by $20M

• Amgen press release (NASDAQ:AMGN): Q4 Non-GAAP EPS of $4.36 beats by $0.35.
• Revenue of $6.85B (+3.3% Y/Y) misses by $20M.
• Revenue from the Eli Lilly and Company (Lilly) COVID-19 manufacturing collaboration. Product sales decreased 1% globally for the fourth quarter.
• Additionally, the Company will provide financial guidance for 2022 and longer-term financial guidance through the end of the decade.

AMGN